Search clinical trials for: XELOXA

Total 857 results

The First People's Hospital of Changzhou

Unknown

SOX Versus XELOX for Patients With Peritoneal Metastasis of Colorectal Cancer

Colorectal Neoplasm

China
Dong-A University Hospital

Terminated

XELOX Versus FOLFOX for Advanced Gastric Cancer (AGC)

Gastric Carcinoma Stage IV

Korea, Republic of
Samsung Medical Center

Withdrawn

Trial Comparing Capecitabine Plus Oxaliplatin (XELOX) and Capecitabine (X) as First-line Chemotherapy in Elderly Patients With Advanced Gastric Cancer

Gastric Cancer

Korea, Republic of
Tianjin Medical University Cancer Institute and...

Unknown

Trial of Adjuvant Chemotherapy for High Risk Gastric Cancer Patients

Stomach Cancer

China
Fudan University
Shanghai Jiao Tong University School of Medicine; Tongji University; Zhejiang...

Unknown

Laparoscopic Surgery VS Laparoscopic Surgery + Neoadjuvant Chemotherapy for T4 Tumor of the Colon Cancer

Colonic Neoplasms
Spanish Cooperative Group for the Treatment of...
Sanofi; Roche Pharma AG

Completed

Study of Bevacizumab Alone or Combined With Capecitabine and Oxaliplatin as Support Therapy in Metastatic Colorectal Cancer Patients

Colorectal Cancer

Spain
National University Hospital, Singapore
The N.1 Institute for Health (N.1)

Recruiting

PRECISE CURATE.AI Pilot Clinical Trial

Solid Tumor

Singapore
Fudan University

Suspended

Combination of Capecitabine and Oxaliplatin in Patients With Relapsed or Refractory Gastric Cancer

Gastric Cancer

China
Hallym University Medical Center
Sanofi

Completed

Oxaliplatin and S-1 (OS) Versus Oxaliplatin and Capecitabine (XELOX) for Advanced Colorectal Cancer

Colorectal Neoplasm

Korea, Republic of
Tang-Du Hospital

Recruiting

New Adjuvant Treatment of Locally Advanced Resectable Gastric Cancer With Carelizumab and XELOX

Gastric Cancer

China
Emory University
Novartis

Completed

Trial of XELOX Followed by Radiation Combined With Carboplatin and RAD001 for Esophageal Cancer

Esophageal Cancer | Neoplasms, Esophageal

United States
Hoffmann-La Roche

Completed

A Study of Xeloda (Capecitabine) Plus Radiotherapy in Participants With Locally Advanced Rectal Cancer

Colorectal Cancer

Slovakia
West China Hospital

Completed

Early Evaluation of Chemosensitivity for Low/Intermediated-risk Mid-low Stage II/III Rectal Cancer

Rectal Cancer

China
Shanghai Zhongshan Hospital
Fudan University; RenJi Hospital; Ruijin Hospital; Xinhua Hospital, Shanghai Jiao...

Unknown

Oxaliplatin Plus Capecitabine in the Perioperative Treatment of Locally Advanced Gastric Adenocarcinoma (Neo-Classic)

Gastric Adenocarcinoma

China
Peking University Cancer Hospital & Institute

Not yet recruiting

KN026 Plus Chemotherapy ± KN-046 in HER2 Positive Colorectal Cancer and Biliary Carcinoma

HER2-positive Colorectal Cancer | HER2-positive Biliary Tract Cancer

China
Harbin Medical University
Sun Yat-sen University; Fudan University; Cancer Institute and Hospital, Chinese... and other collaborators

Unknown

XELOX and XELIRI Alternative Regimen as First-line Treatment for Advanced Colorectal Cancer

Colorectal Neoplasms | Chemotherapy

China
Niguarda Hospital

Completed

Total Neoadjuvant Treatment Without Surgery For Locally Advanced Rectal Cancer (NO-CUT)

Colo-rectal Cancer

Italy
Pia Osterlund

Recruiting

Study of Bevacizumab in Combination With Alternating Xeliri and Xelox in Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

Finland
InterHealth Nutraceuticals, Inc.
MB Clinical Research, LLC

Completed

Effect of Relora Supplement on Anxiety, Cognitive Performance & Mood Tested After Induced Stress

Mood (Psychological Function)

United States
Peking University

Not yet recruiting

Phase 2 Trial of KN026+KN046±XELOX in HER2-positive Locally Advanced GC

HER2-positive Locally Advanced Resectable Gastric Cancer
King Abdullah Medical City
King Faisal Specialist Hospital & Research Center; King Saud Medical City; Al...

Recruiting

Phase II/III Study to Assess the Efficacy of Neoadjuvant Consolidation Chemotherapy in Rectal Cancer Patients.

Rectal Cancer

Saudi Arabia
Sun Yat-sen University

Recruiting

Chemotherapy Alone Versus Surgery Plus Chemotherapy for Distal Gastric Cancer With One Non-curable Factor

Gastric Cancer

China
Catholic University of the Sacred Heart

Unknown

Preoperative Downstaging of Extraperitoneal T3 Rectal Cancer: XELOXRT Versus XELACRT. A Multicenter, Phase III Study (INTERACT)

Rectal Cancer

Italy
University of Aarhus
Pierre Fabre Laboratories

Completed

Phase II Trial With Metronomic, Capecitabine Plus Oral Vinorelbine for Metastatic Breast Cancer (XeNa)

Breast Cancer

Denmark
Affiliated Cancer Hospital & Institute of Guangzhou...
Zhejiang Cancer Hospital; Guangdong Provincial Hospital of Traditional Chinese... and other collaborators

Unknown

Efficacy of HIPEC in the Treatment of Locally Advanced Gastric Cancer After radIcal Gastrectomy With D2 (EHTLAGCRGD2)

Gastric Cancer

China
Third Affiliated Hospital, Sun Yat-Sen University
Jiangsu Hengrui Pharmaceutical Co., Ltd.

Recruiting

Carrelizumab (PD-1) Combined With Chemotherapy in Neoadjuvant Treatment of Locally Advanced Gastric Cancer

Locally Advanced Gastric Cancer

China
Zhejiang Cancer Hospital

Unknown

Abraxane Combined With Xeloda as Neo-Adjuvant Chemotherapy in Early Breast Cancer

Breast Cancer
Lin Chen

Recruiting

Tirelizumab Combined With Chemotherapy in the Treatment of HER-2 Negative Locally Advanced Gastric Cancer

Efficacy | Safety | HER2 Negative | Locally Advanced Gastric Carcinoma

China
Henan Cancer Hospital

Not yet recruiting

Disitamab Vedotin Combined With Sintilimab and XELOX Perioperative Treatment for Resectable Gastric Caner With HER2 Overexpression

Gastric Cancer

China
National Cancer Institute, Egypt

Completed

Study of Metronomic Capecitabine and Oxaliplatin Versus XELOX in Egyptian Metastatic Colorectal Cancer Patients

Toxicity | Survival | Clinical Response
Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Recruiting

A Clinical Studyf of SHR-1701 or Placebo in Combination With BP102 and XELOX in the First-line Treatment of mCRC

Metastatic Colorectal Cancer (mCRC)

China
Hoffmann-La Roche

Completed

A Study to Assess Capecitabine (Xeloda®) in Patients With Locally Advanced or Metastatic Breast Cancer

Breast Cancer

China, United States, South Africa, Russian Federation, Thailand, Bosnia and Herzegovina, Czech Republic, India, Poland
Cancer Institute and Hospital, Chinese Academy...
Xijing Hospital; Peking Union Medical College Hospital; Peking University Cancer... and other collaborators

Active, not recruiting

A Study of Total Neoadjuvant Therapy for High-risk Locally Advanced Rectal Cancer

Rectal Cancer

China
Cook Group Incorporated

Completed

Treatment of Colonic Obstruction With Cook Evolution® Colonic Stent System

Large Bowel Obstruction | Colonic Obstruction | Colonic Stricture

France, Spain, Denmark, Netherlands, Canada, Italy, United Kingdom
Xiangdong Cheng
Shanxi Province Cancer Hospital; The Second Affiliated Hospital of Harbin Medical... and other collaborators

Not yet recruiting

Tislelizumab Combined With Neoadjuvant Chemotherapy Used in the Perioperative Treatment.

Gastric Cancer

China
Xiaofeng Chen

Recruiting

XELOX Combined With Fruquintinib and Sintilimab Regimen Conversion Therapy for Gastric Cancer/Gastroesophageal Junction Adenocarcinoma Only With Liver and/or Retroperitoneal Lymph Node Metastasis, a Prospective Single-arm, Multicenter Study

Gastric Cancer/Gastroesophageal Junction Adenocarcinoma

China
Bio-Cancer Treatment International Limited
The University of Hong Kong

Completed

Pegylated Recombinant Human Arginase 1 in Combination With Oxaliplatin and Capecitabine for the Treatment of HCC (PACOX)

Hepatocellular Carcinoma

Hong Kong
Swedish Medical Center
Roche Pharma AG

Completed

Gemcitabine and Capecitabine in Patients With Advanced Pancreatic Cancer

Pancreatic Cancer

United States
Sun Yat-sen University

Recruiting

Comparing Modified XELOX Plus Sintilimab With Standard XELOX Plus Sintilimab in First-line Treatment for HER2-negative Gastric/Gastroesophageal Junction Adenocarcinoma

Gastric Cancer

China
Fudan University

Unknown

A Phase Ⅱ Study of XELOX Chemotherapy With or Without Surgery of Primary Lesion for Colon Cancer Patients

Metastatic Colon Cancer

China
University of Wisconsin, Madison

Completed

Capecitabine Pharmacokinetics(PK)-Actual Versus Ideal Body Weight

Neoplasms | Obesity

United States
Hospital San Carlos, Madrid
Complexo Hospitalario Universitario de A Coruña

Completed

Standard Versus Continuous Capecitabine in Advanced Breast Cancer

Metastatic Breast Cancer

Spain
Qilu Pharmaceutical Co., Ltd.

Unknown

A Bioequivalence Study of Capecitabine Tablets 500 mg in Adult Cancer Patients Under Fed Condition (Capecitabine)

Breast Cancer | Colon Cancer
The Catholic University of Korea

Unknown

Phase 3 Study of Xelox Followed by Maintenance Capecitabine in the Advanced Gastric Cancer

Stomach Neoplasms

Korea, Republic of
Samsung Medical Center
Roche Pharma AG

Terminated

Xeloda Maintenance Versus BSC in Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

Korea, Republic of
Hoffmann-La Roche

Completed

A Study of Capecitabine (Xeloda) in Patients With Metastatic Colorectal Cancer

Colorectal Cancer

Bulgaria
Sun Yat-sen University

Unknown

Phase II Study of Maintenance Capecitabine to Treat Resectable Colorectal Cancer (CAMCO)

Colorectal Neoplasms

China
National University Hospital, Singapore

Completed

Study of Capecitabine In Patients With Solid Tumors

Solid Tumors

Singapore
Tianjin Medical University

Unknown

Efficacy and Safety Of Xeloda as Sequential Adjuvant Therapy After Chemotherapy in Breast Cancer

Breast Cancer

China
Institute of Oncology Ljubljana

Completed

Capecitabine as Radiosensitising Agent in Neoadjuvant Treatment of Locally Advanced Resectable Rectal Cancer

Resectable Rectal Cancer Clinical Stage II and III

Slovenia

Search clinical trials for: XELOXA

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ghana

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations